by | Feb 2, 2025 | Uncategorized
Suzetrigine, a new non-opioid pain relief drug sold under the brand name Journavx marks the first new class of pain reliever to receive FDA approval in over two decades.
by | Feb 2, 2025 | Uncategorized
Researchers have found that flossing at least once a week can significantly reduce stroke risk.
Recent Comments